Toby Ferguson's most recent trade in Voyager Therapeutics Inc was a trade of 10,086 Common Stock done at an average price of $3.4 . Disclosure was reported to the exchange on April 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Voyager Therapeutics Inc | Toby Ferguson | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 3.43 per share. | 02 Apr 2025 | 10,086 | 157,914 (0%) | 0% | 3.4 | 34,595 | Common Stock |
| Voyager Therapeutics Inc | Toby Ferguson | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 126,000 | 126,000 | - | - | Stock Option (Right to Buy) | |
| Voyager Therapeutics Inc | Toby Ferguson | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 63,000 | 168,000 (0%) | 0% | 0 | Common Stock | |
| Voyager Therapeutics Inc | Toby Ferguson | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 105,000 | 105,000 (0%) | 0% | 0 | Common Stock | |
| Voyager Therapeutics Inc | Toby Ferguson | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2024 | 210,000 | 210,000 | - | - | Stock Option (Right to Buy) |